2023 - Research.com Microbiology in Switzerland Leader Award
2022 - Research.com Microbiology in Switzerland Leader Award
2013 - European Society for Clinical Microbiology and Infectious Diseases Excellence Award
His primary scientific interests are in Microbiology, Plasmid, Gene, Enterobacteriaceae and Antibacterial agent. Patrice Nordmann combines subjects such as Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae, Escherichia coli with his study of Microbiology. His work deals with themes such as Carbapenem, Drug resistance, Polymerase chain reaction and Cephalosporin, which intersect with Plasmid.
His Gene study introduces a deeper knowledge of Genetics. In the field of Enterobacteriaceae, his study on Enterobacteriaceae Infections overlaps with subjects such as Indian subcontinent. His research in Antibacterial agent intersects with topics in Ceftazidime, Efflux and Quinolone.
Microbiology, Plasmid, Enterobacteriaceae, Gene and Escherichia coli are his primary areas of study. His studies deal with areas such as Klebsiella pneumoniae and Acinetobacter baumannii as well as Microbiology. His Klebsiella pneumoniae research integrates issues from Multilocus sequence typing and Drug resistance.
His studies in Plasmid integrate themes in fields like Sequence analysis, Polymerase chain reaction and Virology. His work on Carbapenemase-Producing Enterobacteriaceae as part of general Enterobacteriaceae research is frequently linked to Rapid detection, thereby connecting diverse disciplines of science. In his research, Ceftazidime is intimately related to Cephalosporin, which falls under the overarching field of Escherichia coli.
Patrice Nordmann mainly investigates Microbiology, Colistin, Escherichia coli, Enterobacteriaceae and Gene. The Microbiology study combines topics in areas such as Plasmid, Klebsiella pneumoniae, MCR-1 and Acinetobacter baumannii. In his study, which falls under the umbrella issue of Plasmid, Antimicrobial is strongly linked to Multiple drug resistance.
Patrice Nordmann has researched Escherichia coli in several fields, including Carbapenem, Multilocus sequence typing, Fosfomycin and Peritonitis. His Enterobacteriaceae study deals with Antibiotic resistance intersecting with Epidemiology, Carbapenemase producing and Intensive care medicine. His Gene research incorporates themes from Molecular biology and Enzyme.
His scientific interests lie mostly in Microbiology, Colistin, Klebsiella pneumoniae, Enterobacteriaceae and Plasmid. His work carried out in the field of Microbiology brings together such families of science as Ceftazidime and Gene, Escherichia coli. His Colistin study combines topics in areas such as Broth microdilution, Feces, MCR-1 and Multiple drug resistance.
Pediatrics, Internal medicine, Outbreak, Infection control and Intensive care medicine is closely connected to Drug resistance in his research, which is encompassed under the umbrella topic of Klebsiella pneumoniae. The Carbapenemase-Producing Enterobacteriaceae research Patrice Nordmann does as part of his general Enterobacteriaceae study is frequently linked to other disciplines of science, such as Rapid detection, therefore creating a link between diverse domains of science. His Plasmid study is related to the wider topic of Genetics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Global spread of Carbapenemase-producing Enterobacteriaceae.
Patrice Nordmann;Thierry Naas;Laurent Poirel.
Emerging Infectious Diseases (2011)
Metallo-β-Lactamases: the Quiet before the Storm?
Timothy R. Walsh;Mark A. Toleman;Laurent Poirel;Patrice Nordmann.
Clinical Microbiology Reviews (2005)
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Patrice Nordmann;Gaelle Cuzon;Thierry Naas.
Lancet Infectious Diseases (2009)
Multiplex PCR for detection of acquired carbapenemase genes
Laurent Poirel;Timothy R. Walsh;Vincent Cuvillier;Patrice Nordmann.
Diagnostic Microbiology and Infectious Disease (2011)
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
L Silvia Munoz-Price;L Silvia Munoz-Price;Laurent Poirel;Robert A Bonomo;Robert A Bonomo;Mitchell J Schwaber.
Lancet Infectious Diseases (2013)
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
L. Poirel;P. Nordmann.
Clinical Microbiology and Infection (2006)
CTX-M: changing the face of ESBLs in Europe
David M. Livermore;Rafael Canton;Marek Gniadkowski;Patrice Nordmann.
Journal of Antimicrobial Chemotherapy (2006)
Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae
Laurent Poirel;Claire Héritier;Venus Tolün;Patrice Nordmann.
Antimicrobial Agents and Chemotherapy (2004)
Carbapenem resistance in Enterobacteriaceae: here is the storm!
Patrice Nordmann;Laurent Dortet;Laurent Poirel.
Trends in Molecular Medicine (2012)
Emerging carbapenemases in Gram-negative aerobes
P. Nordmann;L. Poirel.
Clinical Microbiology and Infection (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: